Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile Infection.|https://dx.doi.org/10.1001/jamanetworkopen.2025.25252
Clinical burden of Clostridioides difficile infection in infective endocarditis: a single-center experience.|https://dx.doi.org/10.1007/s11739-025-04085-0
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial.|https://dx.doi.org/10.1093/jac/dkaf278
Management of Severe Clostridioides difficile Infection.|https://dx.doi.org/10.1016/j.idc.2025.07.006
Synthetic niclosamide-loaded controlled-release nanospheres with high solubility and stability exerting multiple effects against Clostridioides difficile.|https://dx.doi.org/10.3389/fmicb.2025.1617631
The Impact of Obesity on Clostridioides difficile Infection Outcomes: A Retrospective Cohort Study.|https://dx.doi.org/10.3390/jcm14155459
Akkermansia muciniphila: A key player in gut microbiota-based disease modulation.|https://dx.doi.org/10.1016/j.micres.2025.128317
Mycobiota Dynamics in Inflammatory Bowel Disease: Fungal Biomarkers and Clostridioides difficile Co-infection.|https://dx.doi.org/10.1016/j.micpath.2025.108000
[Therapy of Clostridioides difficile infection].|https://dx.doi.org/10.1007/s15006-025-5159-1
Clostridioides difficile Infections: Epidemiological and Laboratory Data from the Internal Medicine Departments of a Tertiary Care Hospital in Athens, Greece, During the Past Decade.|https://dx.doi.org/10.3390/medicina61081416
